This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Small Cap ETFs Deliver Big Gains for Investors
by Neena Mishra
November was the best month ever for the Russell 2000 index
5 Stocks in Dow ETF That Powered the Best Month Since 1987
by Sweta Killa
Amid rising COVID-19 cases, the Dow Jones wrapped up its best month in more than 30 years after hitting the major milestone of 30,000 for the first time last week.
Novavax (NVAX) Rises Despite U.S. Coronavirus Vaccine Study Delay
by Zacks Equity Research
Novavax (NVAX) to begin a phase III study on NVX-CoV2373, its COVID-19 vaccine candidate in the United States and Mexico in the coming weeks. Shares up.
The Zacks Analyst Blog Highlights: Amazon, Google, Zoom Video, Automatic Data Processing and Moderna
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Google, Zoom Video, Automatic Data Processing and Moderna
Moderna (MRNA) Seeks Nod for Emergency Use of COVID-19 Vaccine
by Zacks Equity Research
Moderna's (MRNA) coronavirus vaccine achieves efficacy rate of 94.1% in primary efficacy analysis. The company files for Emergency Use Authorization to the FDA.
Capri Holdings, Edgewell Personal Care, Moderna, Novavax and Zoom Video highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Capri Holdings, Edgewell Personal Care, Moderna, Novavax and Zoom Video highlighted as Zacks Bull and Bear of the Day
Company News for Dec 1, 2020
by Zacks Equity Research
Companies In The News Are: MRNA, NKLA, GM, SPGI, INFO, NJR
COVID-19 Vaccine Race Heats Up: Drugmarkers on Final Lap
by Ritujay Ghosh
Shares of Moderna, Inc. (MRNA), Pfizer, Inc. (PFE) and AstraZeneca plc (AZN) are poised for substantial gains on encouraging final-stage trial results.
Stellar November Paves the Way for a Solid December: 5 Picks
by Tirthankar Chakraborty
Growth-oriented stocks like General Motors (GM), Malibu Boats (MBUU) and LaZBoy (LZB) are likely to do well this month on vaccine optimism and Yellen's possible appointment as US Treasury Secretary.
Markets Sell, November Overall Great; Plus ZM Q3 Beats
by Mark Vickery
Market indexes were down on this last trading day of November, though it still managed to be an historically strong month for stocks overall.
Positive Development on COVID-19 Vaccine Front
by Zacks Equity Research
Positive Development on COVID-19 Vaccine Front
Vertex (VRTX) Symkevi/Kalydeco Label Expansion Gets EU Nod
by Zacks Equity Research
Vertex (VRTX) gets European approval for label expansion of Symkevi and Kalydeco combination pill in cystic fibrosis patients aged six to 11.
Moderna (MRNA) Amends Coronavirus Vaccine Supply Deal in U.K.
by Zacks Equity Research
Moderna (MRNA) amends its present contract with the United Kingdom government to supply two million additional doses of its coronavirus vaccine candidate, mRNA-1273, upon approval.
Moderna (MRNA) Takes to Lead in Covid Sweepstakes
by Mark Vickery
Overall efficacy has reached 94.1%, with treatment of severe cases of Covid proving 100% effective.
Stock Market News for Nov 30, 2020
by Zacks Equity Research
U.S. stock markets closed higher on Friday amid optimism surrounding COVID-19 vaccine.
5 of the Best Stocks to Buy Heading Into December
by Tirthankar Chakraborty
Progress toward a COVID-19 vaccine and Yellen likely to be selected for a top post certainly bode well for stocks in December. Some of the stocks worth investing in are Buckle (BKE) and Deere (DE).
Biotech ETF (XBI) Hits New 52-Week High
by Sanghamitra Saha
The biotech ETF hits a 52-week high on Nov 27. Can it soar further?
Stocks Continue to Climb Amid More Positive Vaccine Trial Results
by David Borun
The major indices all gain between 2 and 3% as hopes for an effective Covid-19 vaccine promise a "return to normal."
Top Research Reports for Amazon, Alphabet & Zoom Video
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Alphabet Inc. (GOOGL) and Zoom Video Communications, Inc. (ZM).
Markets Gear for a Different Black Friday
by Zacks Equity Research
Markets Gear for a Different Black Friday
Energy on Track for Its Best Month Ever: 5 ETF, Stock Winners
by Sweta Killa
The S&P 500 Energy Index is on track for the best month ever, gaining nearly 40%.
Stock Market News for Nov 27, 2020
by Zacks Equity Research
The Dow and the S&P 500 closed in the red on Wednesday after rise in weekly jobless claims underscored that the recovery in labor market is slowing, as well as a surge in new coronavirus cases.
Black Friday 2020 Has a New Look
by Mark Vickery
$10.3 billion in Black Friday revenues are expected online today, growing 33% year over year.
Equinor (EQNR) Jumps 26.1% MTD: What's Driving the Rally?
by Zacks Equity Research
Improving oil prices on encouraging coronavirus vaccine news aid Equinor (EQNR).
4 Consumer Discretionary Gainers From Positive Vaccine News
by Zacks Equity Research
Positive vaccine news along with a steady rise in consumer spending bode well for discretionary stocks, making it a good time to invest in names like Malibu Boats (MBUU) and YETI Holdings (YETI).